NCT01842230

Study to Investigate the Effect of Atorvastatin on the Pharmacokinetic Properties of Telmisartan/S-amlodipine

A Randomized, Open-label, Single Dose, Two-treatment, Two-period, Two-sequence Crossover Study to Investigate the Effect of Atorvastatin on the Pharmacokinetic Properties of Telmisartan/S-amlodipine After Oral Administration in Healthy Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 24 (actual)
• Sponsor: Chong Kun Dang Pharmaceutical · Industry
• Sex: All
• Age: 20 Years – 45 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to investigate the effect of Atorvastatin on the pharmacokinetic properties of Telmisartan/S-amlodipine

Conditions

• Essential Hypertension
• Hyperlipidemia

Interventions

Type	Name	Description
DRUG	Telmisartan 80mg, S-amlodipine 5mg and Atorvastatin 40mg	* Telmisartan 80mg, S-amlodipine 5mg: 1 tablet, oral, once daily, 1day * Atorvastatin 40mg: 1 tablet, oral, once daily, 2days * over the period I \& II(cross-over)
DRUG	Telmisartan 80mg and S-amlodipine 5mg	* Telmisartan 80mg, S-amlodipine 5mg: 1 tablet, oral, once daily, 1day * over the period I \& II(cross-over)

Timeline

• Start date: 2013-04-01
• Primary completion: 2013-05-01
• Completion: 2013-07-01
• First posted: 2013-04-29
• Last updated: 2013-08-01

Locations

1 site across 1 country: South Korea